Although individuals with severe congenital neutropenia (SCN) receiving granulocyte colony‐stimulating factor (G‐CSF) therapy gain (nearly) physiological levels of neutrophils, they are still prone to infections and periodontal diseases. This evidence concerns the gene CSF3 and infection.